Insider filing · TRDA
Peter S Kim
Director
profile →
Entrada Therapeutics, Inc.
TRDA · Healthcare · 31 filings in 24 months
ticker →
Peter S Kim bought $732K of Entrada Therapeutics (TRDA)
Executed May 13 2024, disclosed Jun 18 2025, 401 days later, against a two-business-day limit.
Value, as filed
$732K
50,000 sh across 2 lots
Executed
May 13 2024
the trade date, as filed
Disclosed
Jun 18 2025
401 days after the trade · past the deadline
Return, 21 sessionsiFrom the disclosed entry session; derived
–
not yet measured
Not yet measured: the 21-session window has not closed, or the prices around it are not on record.
The filer
PKPeter S Kim (Director) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales, 1 filed past the two-business-day deadline), most often in Entrada Therapeutics, Inc. (TRDA).
The name
TRDAHealthcare · Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new c…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→